Acute Decompensated Heart Failure (ADHF)
The term for hypertension with CHF exacerbation is "acute decompensated heart failure" (ADHF), specifically the clinical profile characterized by volume overload and pulmonary/systemic congestion frequently precipitated by acute increase in chronic hypertension 1.
Clinical Terminology and Classification
The ACC/AHA guidelines explicitly describe three clinical profiles of hospitalized HF patients, with the first being "the patient with volume overload, manifested by pulmonary and/or systemic congestion, frequently precipitated by an acute increase in chronic hypertension" 1. This is the most common presentation, accounting for approximately 75% of HF hospitalizations 2.
Alternative Terms in Use
While "acute decompensated heart failure" is the standard term, you may encounter:
- Hypertensive acute heart failure (H-AHF): Used when SBP >140 mmHg at presentation 3, 4
- Acute HF syndrome: A broader umbrella term 1
- Acute decompensated chronic heart failure (ADCHF): When occurring in patients with known chronic HF 2
Important caveat: Recent evidence challenges "hypertensive AHF" as a distinct category due to significant overlap with other AHF phenotypes and lack of specific prognostic distinction or targeted therapy 3. The term "AHF with high SBP at presentation" is increasingly preferred as more clinically meaningful.
Key Diagnostic Recognition
The ACC/AHA guidelines mandate identifying severe hypertension as a common precipitating factor for acute HF, as recognition is critical to guide therapy 1, 5. The 2022 guidelines list "uncontrolled hypertension" among the most common factors precipitating HF hospitalization 6.
Clinical Presentation Features
This profile typically presents with:
- Rapid decompensation (within hours rather than days) 4
- Preserved or relatively preserved EF more commonly than reduced EF 1
- Pulmonary congestion with dyspnea, orthopnea, paroxysmal nocturnal dyspnea 7
- Elevated SBP ≥140 mmHg, often >160 mmHg 3
- Low in-hospital mortality (0-2%) compared to other AHF phenotypes 3
Management Implications
The ESC guidelines specifically recommend that in patients with hypertensive AHF, IV vasodilators should be considered as initial therapy to improve symptoms and reduce congestion (Class IIa, Level B) 7. However, vasodilator trials have shown limited benefit, contributing to downgraded recommendations in recent years 3.
Critical pitfall: Do not confuse this with cardiogenic shock (the second clinical profile), which presents with profound depression of cardiac output, hypotension, and renal insufficiency—requiring entirely different management 1.
The term "acute decompensated heart failure" remains the most appropriate and widely accepted terminology, with specification of hypertension as the precipitating factor when documenting the clinical scenario.